Thanks for your feedback Acaca15.I agree this stock is similar...

Thanks for your feedback Acaca15.

I agree this stock is similar to any startup -spending money to build a business faster than income.

However, startups (like exploration, drug, etc) co's can still be valued (and valuations are typically forward looking, i.e. earnings, PE, etc in next 1 - 3 years).

NAN is transitioning from exploration to production phase and with bluechips like GE and others endorsing their product, i expect that this provides added credence and reduces risk.

the last few announcements seem to put it on track for greater things - plus, looking at their market, competitors, etc - this seems like a low risk/ high reward play to me.

Thanks for your feedback - rgds